ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - soybean oil 60 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; fish oil 30 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l-serine 6.5 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; taurine 1.0 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soybean oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride dihydrate; fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrated; soya bean oil, refined; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; zinc sulfate heptahydrate 0.0178 g / 1000 ml; sodium acetate trihydrate 4.1 g / 1000 ml; potassium chloride 3.48 g / 1000 ml; magnesium sulfate heptahydrate 1.92 g / 1000 ml; sodium glycerophosphate hydrated 3.48 g / 1000 ml; calcium chloride dihydrate 0.574 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2 g / 1000 ml; taurine 1 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; glycine 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; olive oil; soya bean oil, refined; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 2 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5 g / 1000 ml; l-histidine 3 g / 1000 ml; glycine 11 g / 1000 ml; l-arginine 12 g / 1000 ml; l- alanine 14 g / 1000 ml

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - aluminium hydroxide; magnesium hydroxide; simethicone - תרחיף - aluminium hydroxide 175 mg / 5 ml; magnesium hydroxide 200 mg / 5 ml; simethicone 25 mg / 5 ml - antacids with antiflatulents - antacid, antiflatulent, relief of sensation of heatburn.

ישראל - עברית - Ministry of Health

romat ltd - acetylmethionine 20 mg/ml; arginine 2.4 mg/ml - solution for injection - supplement of vitamins, amino acid and sugars

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 104 mg / 0.65 ml - medroxyprogesterone - medroxyprogesterone - * sayana is indicated for long-term female contraception. each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). however, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .since loss of bone mineral density may occur in females of all ages who use sayana long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* use in adolescents (12-18 years)in adolescents, use of sayana is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with sayana during the critical period of bone accretion.sayana has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

merck serono ltd - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - gonal-f followed by chorionic gonadotrophin (hcg), is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf), gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermat

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - follitropin beta - תמיסה להזרקה - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.